Lupin Limited has informed the Exchange regarding a press release dated April 22, 2026, titled "Lupin Launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States".
Lupin Limited has informed the Exchange regarding a press release dated April 22, 2026, titled "Lupin Launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States".